Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw Purchases 18,226 Shares of Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw acquired 18,226 shares of the company’s stock in a transaction that occurred on Friday, January 10th. The shares were acquired at an average cost of $0.73 per share, with a total value of $13,304.98. Following the purchase, the chief executive officer now directly owns 14,966,204 shares of the company’s stock, valued at $10,925,328.92. This trade represents a 0.12 % increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Retractable Technologies Trading Up 2.0 %

Shares of Retractable Technologies stock opened at $0.75 on Tuesday. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.57 and a quick ratio of 5.92. Retractable Technologies, Inc. has a 1 year low of $0.56 and a 1 year high of $1.34. The firm has a market cap of $22.60 million, a PE ratio of -1.40 and a beta of 1.94. The company has a 50 day simple moving average of $0.66 and a two-hundred day simple moving average of $0.84.

Institutional Trading of Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC purchased a new stake in shares of Retractable Technologies, Inc. (NYSE:RVP) during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned approximately 0.12% of Retractable Technologies as of its most recent SEC filing. 7.58% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, StockNews.com initiated coverage on Retractable Technologies in a report on Tuesday. They issued a “hold” rating on the stock.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.